Episode 14 – Jeff Mohler, CEO of IQ Genetix joins us to discuss how AI is impacting Genetics, Genomics & advancing personalized Healthcare.

Genetics has been at the forefront of the news since the pandemic started.  It has been the basis for several of the vaccines and drug therapies developed to fight COVID.   AI's role in expediting the research required to advance these initiatives has been key!

You're not going to want to miss this episode as we talk to Jeff Mohler, CEO of IQ Genetix Laboratories.  Jeff has been in the genetics industry for over 3 decades and has been on the front lines of COVID testing during the pandemic.

Jeff shares with us COVID's impact on expediting advanced technologies, where he sees AI being leveraged today and into the future in the genetics industry, and also how AI will impact how we manage our personal healthcare in the future.

John provides Intro on Jeff and shares his Background:   00:37 – 01:43

Jeff gives some additional info on his background and journey from the research arena into the business side of the genetics industry:   01:44 – 03:02

Don't SUCK Fun Fact about Jeff (Time is not his friend):   03:03 – 04:23

Jeff provides some background on why AI failures have held back adoption of AI in the genetics space:   04:24 -  09:06
 
Jeff shares some insights on the pandemic and how IQ Genetix is unique in the genetics laboratory space and where they are heading in the future with “omics” and AI:  09:07  -  15:26
 
Jeff looks into his genetics & AI crystal ball and predicts what he sees in the very near future:  15:27 – 20:11

  
 20:12 Jeff’s Contact Info:

Email:  JMohler@iqgenetix.com 

Website:   www.iqgenetix.com 

 
Conclusion:  20:56

Bob Miller Intro with Music Fade